HDWAS  
Prescribing in Taiwan  
graphinfo
Insight
Indications of Coxibs under the Taiwan National Health Insurance
2025 04 30 Owen Yang
There is a visible increase in the prescribing of
Coxib Drugs (#M01AH)
. Coxibs are indicated under the Taiwan National Health Insurance for individuals at age >60 years with osteoarthritis or individuals at any age with immune arthritis, acute severe trauma, acute stroke or acute coronary artery events, liver cirrhosis, history of peptic ulcer, or use of corticosteroids or anticoagulants.
In 2017 some lower-cost Coxibs can be prescribed additionally for individuals at age >50 years with osteoarthritis.